Cannabix Technologies Inc. (CSE:BLO)(OTC:BLOZF)Detailed Quote · Free Stock Analysis
President of Cannabix Technologies Inc. (OTC: BLOZF) (CSE: BLO) Kal Malhi recently sat down with CFN’s Dan Wise at this years Marijuana Investor Summit (MIS) 2015. In this interview Dan Wise asks Kal Malhi a number of questions relating to his expert team, development status, and target markets.
Cannabix Technologies Inc. is the developer of the patent pending Cannabix Marijuana Breathalyzer for law enforcement. The Cannabix Marijuana Breathalyzer drug-impairment recognition system is based on breath testing technology that has been developed in Sweden and has been clinically researched to be successful in testing individuals for recent consumption of the THC component of marijuana. The Company is advancing its products to enable law enforcement personnel to use this technology to enhance detection of marijuana impaired driving offenses on North American roads at a time when marijuana is becoming legal in many jurisdictions. The Company’s drug-testing device will detect Tetrahydrocannabinol (THC- the psychoactive component of marijuana that causes intoxication) using breath samples. The device will provide rapid detection of THC and can be used roadside to identify drivers intoxicated by the use of marijuana. The device can also be useful for other practical applications such as testing employees in the workplace where intoxication by THC can be hazardous.
- Cannabix Set to Begin Trials in BC with New Hire
- Marijuana & Driving: A Review of the Studies & Legal Challenges
- Cannabix Looks to Solve Roadside THC Testing Issues
- Canadian Cannabis Task Force Cites Impaired Driving as a ‘Serious Issue’ Demanding ‘Immediate Attention’
- Marijuana Breathalyzer Moves Closer to Reality
Around the Web
- Cannabix Set to Begin Trials in BC with New Hire — CFN Media
- Cannabix Technologies Adds Dr. David Hasman to Initiate Marijuana Breathalyzer Trials in British Columbia
- Marijuana & Driving: A Review of the Studies & Legal Challenges — CFN Media
- Cannabix Looks to Solve Roadside THC Testing Issues — CFN Media
- Live Testing with Cannabix Marijuana Breathalyzer Shows Excellent Sensitivity for THC and Related Metabolites
Follow Us on Social Media
About CFN Media
CFN Media (CannabisFN) is the leading creative agency and media network dedicated to legal cannabis. We help marijuana businesses attract investors, customers (B2B, B2C), capital, and media visibility. Private and public marijuana companies and brands in the US and Canada rely on CFN Media to grow and succeed.
CFN launched in June of 2013 to initially serve the growing universe of publicly traded marijuana companies across North America. Today, CFN Media is also the digital media choice for the emerging brands in the space.
Disclaimer: Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: http://www.cannabisfn.com/legal-disclaimer/.